Decades of agonizing delays in major depressive disorder treatment may finally be coming to an end, as two pivotal studies—a February 2026 clinical evaluation from the University of California, Los ...

As someone who has spent the last decade driving the advancement of flow cytometry technology and its real-world applications ...

Oral presentation to feature 99-patient dataset with extended follow-up in newly diagnosed NPM1-m or KMT2A-r AML –– High CRc rates (90–96%) ...

The Zacks Medical - Products industry is navigating a difficult operating environment, shaped by rising tariff pressures and ...

Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR exon 20 insertion mutant NSCLC expected mid-2026IND clearance of ARR-002, ArriVent's dual-targeting MUC16/NaPi2b tetravalent AD ...

USA: The FDA has alerted healthcare providers about an increased risk of developing new primary hematologic malignancies ...

Photopharmacology combines light and drug action, offering reversible control over biological pathways, transforming ...

Gold Spot US Dollar, Dow Jones Industrial Average, US Small Cap 2000, S&P/ASX 200. Read 's Market Analysis on Investing.com ...

Q1 2026 Earnings Call May 13, 2026 4:30 PM EDTCompany ParticipantsPeter Mariani - Chief Financial OfficerPhillip Chan - ...

In 2026, the biotech landscape has undergone a seismic shift, moving beyond the hype cycles of the past decade into a phase of tangible, life-saving applications. With the first wave of CRISPR-based ...

May 13, 2026 ? Exus Renewables North America, a leading independent owner, developer and operator of utility-scale renewable ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...